查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1944428

全球長效注射劑（LAI）市場：產業分析、市場規模、佔有率及2025-2032年預測（依產品類型、給藥途徑、應用、最終用戶、國家及地區分類）

Long-acting injectables (LAIs) Market, By Product Type, By Route of Administration, By Application, By End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 365 Pages | 商品交期: 2-3個工作天內

價格
簡介目錄

預計到 2024 年，長效注射劑 (LAI) 市場規模將達到 168.603 億美元，並預計從 2025 年到 2032 年將以 13.01% 的複合年成長率成長。

長效注射裝置（LAI）是一種機器人末端執行器，它利用電動馬達而非氣動或液壓系統來抓取、固定和釋放物體。這些裝置被廣泛整合到工業機器人、協作機器人和自動化設備中，以實現精確可靠的物料搬運。這些抓手採用伺服或步進電機，能夠精確控制手指和爪子的運動，從而調節抓取力、速度和位置。這種精確控制確保了高重複性和高精度，使LAI成為處理易碎、小型或不規則形狀零件的理想選擇。

長效注射劑（LAI）市場動態

藥物依從性的提高和慢性病的高發生率預計將推動市場需求。

與每日口服藥物相比，長效注射劑（LAI）能夠顯著提高患者的用藥依從性，從而推動了LAI市場的成長。慢性疾病，尤其是精神疾病，例如思覺失調症和躁鬱症，往往存在用藥依從性差的問題，這會導致疾病復發、頻繁住院和醫療成本增加。 LAI可在數週至數月內持續釋放藥物，無需每日給藥，並能維持體內穩定的治療濃度。這種簡化的治療方案不僅簡化了治療流程，還降低了復發風險，減少了住院次數，並減輕了醫療系統的整體壓力。減少注射頻率提高了患者的便利性，並有助於疾病的長期管理，因此LAI越來越受到醫護人員和患者的青睞。

此外，慢性病和長期疾病（例如精神疾病、愛滋病、糖尿病和荷爾蒙失衡）的日益普遍也推動了市場需求。隨著全球人口老化和文明病的不斷增加，對能夠提供持續可靠治療的療法的需求正在迅速成長。長效注射劑（LAI）在治療精神疾病和慢性感染疾病等疾病方面具有獨特的優勢，因為在這些疾病中，穩定的藥物濃度至關重要，但每日口服藥物的依從性卻難以保證。 LAI 可在數週至數月內持續釋放藥物，有助於降低因漏服藥物而導致的疾病進展和住院風險。此外，患有這些慢性疾病的患者數量不斷成長，顯著擴大了 LAI 的潛在市場，從而推動了已開發經濟體和新興經濟體的強勁需求。醫療保健提供者傾向於選擇能夠改善患者預後、減輕醫療基礎設施壓力並促進長期疾病管理的解決方案，這進一步強化了這一趨勢。

長效注射劑（LAI）市場：細分分析

全球長效注射劑 (LAI) 市場按產品類型、給藥途徑、適應症、最終用戶和地區進行細分。

根據產品類型，市場可分為四大類：抗精神病藥物、荷爾蒙藥物、抗感染藥和其他藥物。到2024年，抗精神病藥物將佔據主要市場。這些藥物主要用於治療思覺失調症、躁鬱症和其他慢性精神疾病。長效抗精神病藥物可維持數週至數月的穩定治療藥物濃度，從而降低復發風險，並最大限度地減少因藥物濃度波動引起的副作用。

根據應用領域，市場可分為五大類：精神疾病、愛滋病/HIV、疼痛及慢性疾病、內分泌疾病和其他疾病。精神疾病領域在長效注射劑（LAI）市場中佔據主導地位，這主要歸因於患者群體龐大、疾病的慢性特徵、口服藥物依從性方面的挑戰，以及持續治療帶來的顯著臨床獲益。長效注射劑可降低復發率、住院率，並減輕醫療保健系統的整體負擔。它們提供可預測且持續的治療，這對於嚴重的精神疾病尤其重要，因為漏服藥物可能會造成嚴重後果。

長效注射劑（LAI）市場－區域分析

北美目前在長效注射劑（LAI）市場佔據領先地位，這主要得益於精神科護理中LAI的廣泛應用、強大而完善的醫療保健基礎設施、全面的保險覆蓋以及早期獲得創新療法的機會。美國是該地區的主要貢獻者，這主要歸功於醫療保健提供者和患者對LAI益處（提高治療依從性、降低復發率和最佳化長期疾病管理）的認知不斷提高。持續的產品上市以及更新、更便捷的製劑的出現進一步鞏固了美國市場。歐洲擁有第二大市場佔有率，其中德國、法國和英國等國家在LAI的應用上處於領先地位。該地區的成長得益於結構化的精神健康計畫、慢性精神和內分泌疾病發病率的上升以及對長效荷爾蒙療法的需求不斷成長。

目錄

第1章 長效注射劑（LAI）市場概覽

  • 分析範圍
  • 市場估算期

第2章執行摘要

  • 市場區隔
  • 競爭考察

第3章 長效注射劑（LAI）的主要市場趨勢

  • 市場促進因素
  • 市場限制
  • 市場機遇
  • 未來市場趨勢

第4章 長效注射劑（LAI）市場：產業分析

  • PEST分析
  • 波特五力分析
  • 市場成長展望：概覽
  • 管理體制分析

第5章 長效注射劑（LAI）市場：地緣政治緊張局勢加劇的影響

  • 新冠疫情的影響
  • 俄烏戰爭的影響
  • 中東衝突的影響

第6章 長效注射劑（LAI）的市場現狀

  • 長效注射劑（LAI）市佔率分析（2024 年）
  • 主要製造商的細分數據
    • 對現有公司的分析
    • 新興企業分析

7. 長效注射劑（LAI）市場依產品類型分類

  • 概述
    • 細分市場佔有率分析：依產品類型
    • 抗精神病藥物
    • 荷爾蒙
    • 抗感染藥物
    • 其他

8. 依給藥途徑分類的長效注射劑（LAI）市場

  • 概述
    • 細分市場佔有率分析：依管理途徑
    • 肌肉內注射
    • 靜脈注射（IV）
    • 皮下

9. 按應用分類的長效注射劑 (LAI) 市場

  • 概述
    • 細分市場佔有率分析：按應用
    • 精神疾病
    • 愛滋病毒/愛滋病
    • 疼痛/慢性疾病
    • 內分泌疾病
    • 其他

第10章 依最終用戶分類的長效注射劑（LAI）市場

  • 概述
    • 細分市場佔有率分析：依最終用戶分類
    • 醫院
    • 診所和專科醫療中心
    • 其他

第11章 各地區長效注射劑（LAI）市場

  • 介紹
  • 北美洲
    • 概述
    • 北美主要製造商
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲主要製造商
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
    • 荷蘭
    • 瑞典
    • 俄羅斯
    • 波蘭
    • 其他
  • 亞太地區
    • 概述
    • 亞太地區主要製造商
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 印尼
    • 泰國
    • 菲律賓
    • 其他
  • 拉丁美洲
    • 概述
    • 拉丁美洲主要製造商
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 其他
  • 中東和非洲（MEA）
    • 概述
    • 中東和非洲的主要製造商
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • 其他

第12章 關鍵供應商分析－長效注射劑（LAI）產業

  • 競爭對手儀錶板
    • 競爭基準
    • 競爭定位
  • 公司簡介
    • Johnson &Johnson
    • Pfizer
    • Eli Lilly
    • ViiV Healthcare
    • Teva Pharmaceuticals
    • Alkermes
    • Lupin Limited
    • Amneal Pharmaceuticals
    • Sanofi
    • Novartis
    • Bristol-Myers Squibb
    • GlaxoSmithKline（GSK）
    • AbbVie
    • Roche
    • Sun Pharmaceutical Industries
    • Others

第13章：分析師視角360度分析

簡介目錄
Product Code: ANV6000

Long-acting injectables (LAIs) Market size was valued at USD 16,860.30 Million in 2024, expanding to a CAGR of 13.01% from 2025 to 2032.

A Long-acting injectables (LAIs) is a robotic end-of-arm device designed to pick, secure, and release objects by using electric motors rather than pneumatic or hydraulic systems. It is widely integrated with industrial robots, collaborative robots, and automated equipment for accurate and reliable material handling. These grippers function using servo or stepper motors that precisely control the movement of fingers or jaws, enabling adjustable gripping force, speed, and positioning. This precise control delivers high repeatability and accuracy, making Long-acting injectables (LAIs)s well suited for handling fragile, small, or irregularly shaped components.

Long-acting injectables (LAIs) Market- Market Dynamics

Improved medication adherence along with high prevalence of chronic disorders is anticipated to propel market demand

Long-acting injectables (LAIs) have the ability to significantly enhance medication adherence compared with daily oral treatments, boosting LAIs market growth. Chronic conditions, particularly psychiatric disorders such as schizophrenia and bipolar disorder, often face high rates of non-adherence, leading to disease relapse, frequent hospitalizations, and increased healthcare costs. LAIs provide a sustained release of medication over several weeks or months, eliminating the need for daily dosing and maintaining steady therapeutic levels in the body. This streamlined approach not only simplifies treatment routines but also reduces relapse risk, decreases hospital admissions, and alleviates the overall burden on healthcare systems. The reduced frequency of injections improves patient convenience, supports better long-term disease management, and makes LAIs an increasingly preferred option for both healthcare providers and patients.

Moreover, the rising prevalence of chronic and long-term health conditions, including psychiatric disorders, HIV/AIDS, diabetes, and hormonal imbalances also contributing to market demand. As global populations age and lifestyle-related illnesses become increasingly widespread, the need for therapies that provide continuous and reliable treatment is growing rapidly. LAIs are particularly advantageous in managing conditions where maintaining consistent drug levels is essential and where daily oral adherence is often difficult, such as in mental health or chronic infectious diseases. By offering sustained drug release over weeks or months, LAIs help mitigate the risks associated with missed doses, including disease progression and hospitalization. Moreover, the growing number of patients affected by these chronic conditions significantly expands the potential market for LAIs, driving strong demand across both developed and emerging regions. This trend is further reinforced by healthcare providers' preference for solutions that improve patient outcomes, reduce the burden on medical infrastructure, and promote long-term disease management.

Long-acting injectables (LAIs) Market- Segmentation Analysis:

The Global Long-acting injectables (LAIs) Market is segmented on the basis of Product Type, Route of Administration, Application, End User, and Region.

The market is divided into four categories based on Product Type: antipsychotics, hormonal agents, anti-infectives, and others. Antipsychotics segment hold major share in 2024. These formulations are primarily used to treat schizophrenia, bipolar disorder, and other chronic psychiatric conditions. Long-acting antipsychotics provide steady therapeutic drug levels over weeks or months, reducing the risk of relapse and minimizing side effects associated with fluctuating drug levels.

The market is divided into five categories based on Application: psychiatric disorders, HIV/AIDS, pain & chronic diseases, endocrine disorders, and others. Psychiatric disorders segment leads the LAI market due to the combination of large patient populations, chronic nature of illnesses, adherence challenges with oral medications, and strong clinical benefits of long-acting therapy. LAIs reduce relapse rates, hospital admissions, and the overall burden on healthcare systems. They provide predictable, consistent treatment, which is particularly important in severe psychiatric disorders where missed doses can have serious consequences.

Long-acting injectables (LAIs) Market- Geographical Insights

North America currently leads the Long-Acting Injectables (LAIs) market, driven by the widespread adoption of LAIs in psychiatric care, strong and well-established healthcare infrastructure, comprehensive insurance coverage, and early access to innovative therapies. The United States is the dominant contributor within the region, benefiting from increasing awareness among healthcare providers and patients about the advantages of LAIs in improving treatment adherence, reducing relapse rates, and optimizing long-term disease management. Continuous product launches and the availability of newer, more convenient formulations further strengthen the U.S. market. Europe holds the second-largest market share, with countries such as Germany, France, and the United Kingdom leading in adoption. The region's growth is supported by structured mental health programs, rising incidence of chronic psychiatric and endocrine disorders, and increasing demand for long-acting hormonal therapies.

United States- Long-acting injectables (LAIs) Market- Key Insights

The United States region growth is fueled by widespread use in psychiatric care, a strong healthcare infrastructure, and comprehensive insurance coverage. Millions of Americans are affected by chronic psychiatric disorders, such as schizophrenia and bipolar disorder, creating substantial demand for treatments that enhance medication adherence and reduce the risk of relapse. LAIs deliver medication gradually over weeks or months, maintaining stable therapeutic levels, minimizing hospitalizations, and supporting effective long-term disease management. Market growth is further driven by ongoing product innovation, including newer antipsychotic formulations with extended dosing intervals, improved tolerability, and more convenient modes of administration. Increased awareness among healthcare professionals and patients about the clinical advantages and cost-effectiveness of LAIs also accelerates adoption.

Long-acting injectables (LAIs) Market- Competitive Landscape:

The Long-Acting Injectables (LAIs) market in 2025 is moderately competitive, driven by leading global pharmaceutical companies that prioritize product innovation, therapeutic expansion, and strategic market launches. Johnson & Johnson, Pfizer continues to hold major revenue shares, offering a comprehensive portfolio of LAIs across psychiatric and oncology indications. The company's focus on enhancing patient adherence through robust support programs, educational initiatives, and convenient dosing schedules strengthens its market leadership and ensures consistent revenue growth. Both companies are setting benchmarks for innovation, while ongoing competition drives accelerated development of novel delivery technologies and patient-centric solutions, making the LAI sector one of the most dynamic segments in pharmaceuticals today.

Recent Developments:

In 2025, Lupin obtained U.S. FDA approval for its risperidone long-acting injectable, which also received 180-day Competitive Generic Therapy (CGT) exclusivity. This formulation is the first product developed under Lupin's PrecisionSphere LAI technology platform, showcasing the company's innovation in sustained-release injectable therapies.

In December 2025, Teva Pharmaceuticals filed a New Drug Application (NDA) with the U.S. FDA for its olanzapine extended-release injectable suspension (TEV-749), designed as a once-monthly therapy for adults living with schizophrenia.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET KEY PLAYERS

  • Johnson & Johnson
  • Pfizer
  • Eli Lilly
  • ViiV Healthcare
  • Teva Pharmaceuticals
  • Alkermes
  • Lupin Limited
  • Amneal Pharmaceuticals
  • Sanofi
  • Novartis
  • Bristol-Myers Squibb
  • GlaxoSmithKline (GSK)
  • AbbVie
  • Roche
  • Sun Pharmaceutical Industries
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019-2032

  • Antipsychotics
  • Hormonal agents
  • Anti-infectives
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY ROUTE OF ADMINISTRATION- MARKET ANALYSIS, 2019-2032

  • Intramuscular
  • Intravenous (IV)
  • Subcutaneous

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY APPLICATION- MARKET ANALYSIS, 2019-2032

  • Psychiatric disorders
  • HIV/AIDS
  • Pain & chronic diseases
  • Endocrine disorders
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY END USER- MARKET ANALYSIS, 2019-2032

  • Hospitals
  • Clinics & Specialty Centers
  • Others

GLOBAL LONG-ACTING INJECTABLES (LAIS) MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Long-acting injectables (LAIs) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Long-acting injectables (LAIs) Market Snippet by Product Type
    • 2.1.2. Long-acting injectables (LAIs) Market Snippet by Route of Administration
    • 2.1.3. Long-acting injectables (LAIs) Market Snippet by Application
    • 2.1.4. Long-acting injectables (LAIs) Market Snippet by End User
    • 2.1.5. Long-acting injectables (LAIs) Market Snippet by Country
    • 2.1.6. Long-acting injectables (LAIs) Market Snippet by Region
  • 2.2. Competitive Insights

3. Long-acting injectables (LAIs) Key Market Trends

  • 3.1. Long-acting injectables (LAIs) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Long-acting injectables (LAIs) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Long-acting injectables (LAIs) Market Opportunities
  • 3.4. Long-acting injectables (LAIs) Market Future Trends

4. Long-acting injectables (LAIs) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Long-acting injectables (LAIs) Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. Long-acting injectables (LAIs) Market Landscape

  • 6.1. Long-acting injectables (LAIs) Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Long-acting injectables (LAIs) Market - By Product Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
    • 7.1.2. Antipsychotics
    • 7.1.3. Hormonal agents
    • 7.1.4. Anti-infectives
    • 7.1.5. Others

8. Long-acting injectables (LAIs) Market - By Route of Administration

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 8.1.2. Intramuscular
    • 8.1.3. Intravenous (IV)
    • 8.1.4. Subcutaneous

9. Long-acting injectables (LAIs) Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 9.1.2. Psychiatric disorders
    • 9.1.3. HIV/AIDS
    • 9.1.4. Pain & chronic diseases
    • 9.1.5. Endocrine disorders
    • 9.1.6. Others

10. Long-acting injectables (LAIs) Market - By End User

  • 10.1. Overview
    • 10.1.1. Segment Share Analysis, By Route of Administration, 2024 & 2032 (%)
    • 10.1.2. Hospitals
    • 10.1.3. Clinics & Specialty Centers
    • 10.1.4. Others

11. Long-acting injectables (LAIs) Market- By Geography

  • 11.1. Introduction
    • 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 11.2. North America
    • 11.2.1. Overview
    • 11.2.2. Long-acting injectables (LAIs) Key Manufacturers in North America
    • 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.2.5. North America Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.2.6. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.2.7. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.8. U.S.
      • 11.2.8.1. Overview
      • 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.8.4. U.S. Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.8.5. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.8.6. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.2.9. Canada
      • 11.2.9.1. Overview
      • 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.2.9.4. Canada Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.2.9.5. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.2.9.6. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.3. Europe
    • 11.3.1. Overview
    • 11.3.2. Long-acting injectables (LAIs) Key Manufacturers in Europe
    • 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.3.5. Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.3.6. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.3.7. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.8. Germany
      • 11.3.8.1. Overview
      • 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.8.4. Germany Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.8.5. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.8.6. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.9. UK
      • 11.3.9.1. Overview
      • 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.9.4. UK Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.9.5. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.9.6. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.10. France
      • 11.3.10.1. Overview
      • 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.10.4. France Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.10.5. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.10.6. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.11. Italy
      • 11.3.11.1. Overview
      • 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.11.4. Italy Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.11.5. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.11.6. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.12. Spain
      • 11.3.12.1. Overview
      • 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.12.4. Spain Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.12.5. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.12.6. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.13. The Netherlands
      • 11.3.13.1. Overview
      • 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.13.4. The Netherlands Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.13.5. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.13.6. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.14. Sweden
      • 11.3.14.1. Overview
      • 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.14.4. Sweden Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.14.5. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.14.6. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.15. Russia
      • 11.3.15.1. Overview
      • 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.15.4. Russia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.15.5. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.15.6. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.16. Poland
      • 11.3.16.1. Overview
      • 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.16.4. Poland Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.16.5. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.16.6. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.3.17. Rest of Europe
      • 11.3.17.1. Overview
      • 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.3.17.4. Rest of the Europe Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.3.17.5. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.3.17.6. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.4. Asia Pacific (APAC)
    • 11.4.1. Overview
    • 11.4.2. Long-acting injectables (LAIs) Key Manufacturers in Asia Pacific
    • 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.4.5. APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.4.6. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.4.7. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.8. China
      • 11.4.8.1. Overview
      • 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.8.4. China Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.8.5. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.8.6. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.9. India
      • 11.4.9.1. Overview
      • 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.9.4. India Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.9.5. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.9.6. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.10. Japan
      • 11.4.10.1. Overview
      • 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.10.4. Japan Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.10.5. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.10.6. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.11. South Korea
      • 11.4.11.1. Overview
      • 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.11.4. South Korea Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.11.5. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.11.6. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.12. Australia
      • 11.4.12.1. Overview
      • 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.12.4. Australia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.12.5. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.12.6. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.13. Indonesia
      • 11.4.13.1. Overview
      • 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.13.4. Indonesia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.13.5. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.13.6. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.14. Thailand
      • 11.4.14.1. Overview
      • 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.14.4. Thailand Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.14.5. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.14.6. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.15. Philippines
      • 11.4.15.1. Overview
      • 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.15.4. Philippines Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.15.5. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.15.6. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.4.16. Rest of APAC
      • 11.4.16.1. Overview
      • 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.4.16.4. Rest of APAC Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.4.16.5. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.4.16.6. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.5. Latin America (LATAM)
    • 11.5.1. Overview
    • 11.5.2. Long-acting injectables (LAIs) Key Manufacturers in Latin America
    • 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.5.5. LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.5.6. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.5.7. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.8. Brazil
      • 11.5.8.1. Overview
      • 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.8.4. Brazil Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.8.5. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.8.6. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.9. Mexico
      • 11.5.9.1. Overview
      • 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.9.4. Mexico Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.9.5. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.9.6. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.10. Argentina
      • 11.5.10.1. Overview
      • 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.10.4. Argentina Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.10.5. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.10.6. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.11. Colombia
      • 11.5.11.1. Overview
      • 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.11.4. Colombia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.11.5. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.11.6. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.5.12. Rest of LATAM
      • 11.5.12.1. Overview
      • 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.5.12.4. Rest of LATAM Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.5.12.5. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.5.12.6. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 11.6. Middle East and Africa (MEA)
    • 11.6.1. Overview
    • 11.6.2. Long-acting injectables (LAIs) Key Manufacturers in Middle East and Africa
    • 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
    • 11.6.5. MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
    • 11.6.6. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 11.6.7. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.8. Saudi Arabia
      • 11.6.8.1. Overview
      • 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.8.4. Saudi Arabia Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.8.5. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.8.6. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.9. United Arab Emirates
      • 11.6.9.1. Overview
      • 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.9.4. United Arab Emirates Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.9.5. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.9.6. United Arab Emirates Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.10. Israel
      • 11.6.10.1. Overview
      • 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.10.4. Israel Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.10.5. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.10.6. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.11. Turkey
      • 11.6.11.1. Overview
      • 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.11.4. Turkey Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.11.5. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.11.6. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.12. Algeria
      • 11.6.12.1. Overview
      • 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.12.4. Algeria Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.12.5. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.12.6. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.13. Egypt
      • 11.6.13.1. Overview
      • 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.13.4. Egypt Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.13.5. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.13.6. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 11.6.14. Rest of MEA
      • 11.6.14.1. Overview
      • 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
      • 11.6.14.4. Rest of MEA Market Size and Forecast, By Route of Administration, 2019 - 2032 (US$ Million)
      • 11.6.14.5. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 11.6.14.6. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- Long-acting injectables (LAIs) Industry

  • 12.1. Competitive Dashboard
    • 12.1.1. Competitive Benchmarking
    • 12.1.2. Competitive Positioning
  • 12.2. Company Profiles
    • 12.2.1. Johnson & Johnson
    • 12.2.2. Pfizer
    • 12.2.3. Eli Lilly
    • 12.2.4. ViiV Healthcare
    • 12.2.5. Teva Pharmaceuticals
    • 12.2.6. Alkermes
    • 12.2.7. Lupin Limited
    • 12.2.8. Amneal Pharmaceuticals
    • 12.2.9. Sanofi
    • 12.2.10. Novartis
    • 12.2.11. Bristol-Myers Squibb
    • 12.2.12. GlaxoSmithKline (GSK)
    • 12.2.13. AbbVie
    • 12.2.14. Roche
    • 12.2.15. Sun Pharmaceutical Industries
    • 12.2.16. Others

13. 360 Degree Analyst View

14. Appendix

  • 14.1. Research Methodology
  • 14.2. References
  • 14.3. Abbreviations
  • 14.4. Disclaimer
  • 14.5. Contact Us